🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Malignant Pleural Mesothelioma, Advanced

Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site📍 Chicago University of Chicago · Tests: Partial Pleurectomy Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites📍 Shanghai📍 Shanghai📍 Chengdu Ruijin Hospital · Tests: Ivonescimab Combined With Chemotherapy CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites📍 Goodyear📍 Phoenix📍 Duarte IDEAYA Biosciences · Tests: IDE892, IDE397 SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites📍 Tampa📍 Westwood📍 Philadelphia Verismo Therapeutics · Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR A Study of MT027 in Patients with Pleural Malignant Tumors NCT06726564Phase 11 site📍 Beijing Suzhou Maximum Bio-tech Co., Ltd. · Tests: MT027 cells suspension A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776Phase 1, Phase 280 sites📍 Tampa📍 Atlanta📍 Chicago Novartis Pharmaceuticals · Tests: Tulmimetostat, Enzalutamide SW-682 in Advanced Solid Tumors NCT06251310Phase 18 sites📍 Scottsdale📍 Los Angeles📍 Sacramento SpringWorks Therapeutics, Inc., a healthcare company of Mer… · Tests: SW-682, Combination Therapy Evaluation of Skin Tests in Biotherapy Allergies NCT06971848NA1 site📍 Angers University Hospital, Angers · Tests: Drug skin tests (investigating hypersensitivity to a biotherapy) TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma NCT04969315Phase 1, Phase 22 sites📍 Los Angeles📍 Houston Portage Biotech · Tests: TT-10, TT-4 A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674Phase 117 sites📍 Duarte📍 Los Angeles📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-1607, Paclitaxel Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors NCT06566079Phase 1, Phase 210 sites📍 Denver📍 Chicago📍 Cleveland InSilico Medicine Hong Kong Limited · Tests: ISM6331 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors NCT06535607Phase 298 sites📍 Los Angeles📍 Baltimore📍 New York AstraZeneca · Tests: Volrustomig, Cisplatin, Carboplatin, Paclitaxel, 5-FU A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression NCT06051695Phase 1, Phase 212 sites📍 Gilbert📍 La Jolla📍 Los Angeles A2 Biotherapeutics Inc. · Tests: A2B694, A2B543, xT CDx with HLA-LOH Assay A Beta-only IL-2 ImmunoTherapY Study NCT05086692Phase 1, Phase 228 sites📍 San Diego📍 San Francisco📍 Santa Monica Medicenna Therapeutics, Inc. · Tests: MDNA11, Pembrolizumab (KEYTRUDA®) First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma NCT05188859Phase 22 sites📍 Taiyuan📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Sintilimab+Anlotinib+Pemetrexed+Cisplatin HTL0039732 in Participants With Advanced Solid Tumours NCT05944237Phase 1, Phase 26 sites📍 Cambridge📍 Cardiff📍 Dundee Cancer Research UK · Tests: HTL0039732 Capsules, HTL0039732 Capsules or HTL0039732 tablets and atezolizumab infusion APG-2449 in Patients With Advanced Solid Tumors NCT03917043Phase 19 sites📍 Beijing📍 Fuzhou📍 Fuzhou Ascentage Pharma Group Inc. · Tests: APG-2449
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy